MNKD
MannKind CorpNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.04B
P/E Ratio
—
EPS
$-0.07
Beta
1.04
52W High
$6.51
52W Low
$2.23
50-Day MA
$2.80
200-Day MA
$4.57
Dividend Yield
—
Profit Margin
-6.63%
Forward P/E
35.59
PEG Ratio
4.39
About MannKind Corp
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutics for endocrine and orphan lung diseases in the United States. The company is headquartered in Westlake Village, California.
Fundamentals
| Revenue (TTM) | $360.78M |
| Gross Profit (TTM) | $272.87M |
| EBITDA | $35.32M |
| Operating Margin | -3.31% |
| Return on Equity | 0.00% |
| Return on Assets | 2.03% |
| Revenue/Share (TTM) | $1.31 |
| Book Value | $-0.19 |
| Price-to-Book | 187.85 |
| Price-to-Sales (TTM) | 2.89 |
| EV/Revenue | 3.441 |
| EV/EBITDA | 44.98 |
| Quarterly Earnings Growth (YoY) | -34.90% |
| Quarterly Revenue Growth (YoY) | 15.10% |
| Shares Outstanding | $308.95M |
| Float | $304.28M |
| % Insiders | 1.53% |
| % Institutions | 59.28% |
Historical Volatility
HV 10-Day
65.76%
HV 20-Day
94.09%
HV 30-Day
81.98%
HV 60-Day
70.69%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($7.47 target)
7
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026